| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |